Biopharmaceutical research has never been for the faint of heart. For small biotech companies working on the absolute edge of innovation, one clinical trial can literally mean the difference between closing up shop or commercializing a breakthrough, life-saving medicine. And even for big pharmaceutical companies, setbacks have always been inevitable – the nature of discovery means that success comes only after years of trial and error.